Effects of Dividing Carcinogen Doses on Tumor Development in Mice
Author Information
Author(s): M. H. Salaman, F. J. C. Roe
Primary Institution: London Hospital Medical College
Hypothesis
Does splitting the dose of DMBA into two halves increase the incidence of malignant tumors in mice?
Conclusion
Splitting the initiating dose of DMBA into two halves appears to favor the induction of malignant tumors, especially with longer intervals between doses.
Supporting Evidence
- 43 out of 106 surviving mice developed malignant tumors after treatment.
- Groups receiving two half-doses had a higher incidence of tumors than those receiving a single dose.
- Statistical analysis was complicated due to the nature of the data collected.
Takeaway
When scientists gave mice a cancer-causing chemical in two smaller doses instead of one big dose, they found more tumors, especially if they waited a few weeks between doses.
Methodology
Mice were divided into groups and treated with DMBA and croton oil, with varying intervals between doses to observe tumor development.
Limitations
The statistical significance of the results could not be adequately tested.
Participant Demographics
60 male and 60 female mice were used in the study.
Want to read the original?
Access the complete publication on the publisher's website